Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects

Source : https://jnnp.bmj.com/content/early/2021/01/25/jnnp-2020-324674.abstract

Migraine is the second largest cause of years lost to disability globally among all diseases, with a worldwide prevalence over 1 billion. Despite the global burden of migraine, few classes of therapeutics have been specifically developed to combat migraine.